Effective silencing of ENaC by siRNA delivered with epithelial-targeted nanocomplexes in human cystic fibrosis cells and in mouse lung

Tagalakis, Aristides, Mynue, MM, Ivanova, H Chen, Smith, CM, Aldossary, AM and Rosa, LZ (2018) Effective silencing of ENaC by siRNA delivered with epithelial-targeted nanocomplexes in human cystic fibrosis cells and in mouse lung. Thorax. pp. 1-10. ISSN 0040-6376 DOI https://doi.org/10.1136/thoraxjnl-2017-210670

This is the latest version of this item.

Thorax PDF_proof_hi (accepted version).pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (2MB) | Preview
thoraxjnl-2017-210670.full (pages not finalized).pdf - Published Version
Available under License Creative Commons Attribution.

Download (3MB) | Preview


Introduction Loss of the cystic fibrosis transmembrane conductance regulator (CFTR) in cystic fibrosis (CF) leads to hyperabsorption of sodium and fluid from the airway due to upregulation of the epithelial sodium channel (ENaC). Thickened mucus and depleted airway surface liquid (ASL) then lead to impaired mucociliary clearance. ENaC regulation is thus a promising target for CF therapy. Our aim was to develop siRNA nanocomplexes that mediate effective silencing of airway epithelial ENaC in vitro and in vivo with functional correction of epithelial ion and fluid transport. Methods We investigated translocation of nanocomplexes through mucus and their transfection efficiency in primary CF epithelial cells grown at air-liquid interface (ALI). SiRNA-mediated silencing was examined by quantitative RT-PCR and Western analysis of ENaC. Transepithelial potential (Vt), short circuit current (Isc), ASL depth and ciliary beat frequency (CBF) were measured for functional analysis. Inflammation was analysed by histological analysis of normal mouse lung tissue sections. Results Nanocomplexes translocated more rapidly than siRNA alone through mucus. Transfections of primary CF epithelial cells with nanocomplexes targeting αENaC siRNA, reduced αENaC and βENaC mRNA by 30%. Transfections reduced Vt, the amiloride-sensitive Isc, and mucus protein concentration, while increasing ASL depth and CBF to normal levels. A single dose of siRNA in mouse lung silenced ENaC by approximately 30%, which persisted for at least 7 days. Three doses of siRNA increased silencing to approximately 50%. Conclusion Nanoparticle mediated-delivery of ENaC siRNA to ALI cultures corrected aspects of the mucociliary defect in human CF cells and offers effective delivery and silencing in vivo.

Item Type: Article
Uncontrolled Keywords: ALI, nanoparticle, ENaC, cilia, ASL, cystic fibrosis, airway epithelia
Subjects: R Medicine > RT Nursing
Divisions: Biology
Date Deposited: 18 May 2018 11:55
URI: http://repository.edgehill.ac.uk/id/eprint/10345

Available Versions of this Item

Archive staff only

Item control page Item control page